Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 3, 2010, Pages 280-286

  Wang, Jian ^a   Wang, Ping Ping ^a   Xiang, Gui Ju ^b   Hu, Xiao Bin ^b  

^a ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Xinhua Hospital of Huainan   (China)

Author keywords

HBV DNA; Hepatic cirrhosis; Interferon inducible protein 10; mRNA; Peripheral blood mononuclear cells

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; VIRUS DNA; AUTACOID; BIOLOGICAL MARKER; CXCL10 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CIRRHOSIS; MALE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; CHINA; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; VIROLOGY; VIRUS LOAD;

ADULT; BIOLOGICAL MARKERS; CHEMOKINE CXCL10; CHINA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRAL LOAD;

EID: 77953849195     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005;42:S100-107.
2. Chu CM, Liaw YF. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 2009;104:1693-1699.
3. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
4. Xu J, Lin Y, Wang YP, Chen YX, Shi B, Lu J, et al. Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas: a matched casecontrolstudy. J Dig Dis 2009;10:138-144.
5. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol2003;111:1185-1200.
6. Korniejewska A, Watson M, Ward S. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes. Methods Mol Biol 2010;616:125-147.
7. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003;24:765-781.
8. Neville LF, Mathiak G, Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 1997;8:207-219.
9. Luster AD, Unkeless JC, Ravetch JV. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985;315:672-676.
10. Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 2007;14:675-687.
11. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163:6236-6243.
12. Wang J, Zhao JH, Wang PP, Xiang GJ. Expression of CXC chemokine IP-10 in patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 2008;7:45-50.
13. Chuang YH, Lian ZX, Cheng CM, Lan RY, Yang GX, Moritoki Y, et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 2005; 25:126-132.
14. Zhao JH, Wang J, Jiang SQ, Xiang GJ. Expression of chemokine monokine induced by interferon-gama in patients with chronic hepatitis B. Nan Fang Yi Ke Da Xue Xue Bao 2006;26:1589-1592.
15. Wang J, Wang PP, Xiang GJ. Antibody against interferon-α 2b in serum of the patients with chronic hepatitis C and its clinical significance: a clinical trial. Hepatitis Monthly 2009;9:103-109.
16. Deng G, Zhou G, Zhang R, Zhai Y, Zhao W, Yan Z, et al. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 2008;134:716-726.
17. Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, et al. Intrahepatic levels of CXCR3- associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008;48:1440-1450.
18. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008;6:1315-1341.
19. Harvey CE, Post JJ, Palladinetti P, Freeman AJ, Ffrench RA, Kumar RK, et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 2003;74:360-369.
20. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000;191:1269-1280.
21. Reiberger T, Aberle JH, Kundi M, Kohrgruber N, Rieger A, Gangl A, et al. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. Antivir Ther 2008;13:969-976.
22. Larrubia JR, Benito-Martínez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 2008;14:7149-7159.
23. Zhao X, Town JR, Li F, Zhang X, Cockcroft DW, Gordon JR. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol 2009; 182:3213-3222.
24. Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol 2008;173:643-652.